EMA RECEIVES APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF COVID-19 VACCINE JANSSEN, , 16/02/2021
(AGENPARL) – LONDON (UNITED KINGDOM), mar 16 febbraio 2021 EMA has received an application for conditional marketing authorisation (CMA) for a COVID-19 vaccine developed by Janssen-Cilag International N.V. EMA’s human medicines committee (CHMP) will assess the vaccine, known as COVID-19 Vaccine Janssen, under an accelerated timetable. The Committee could issue......